Page last updated: 2024-08-23

teprotide and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

teprotide has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abiru, S; Aratake, K; Arima, K; Eguchi, K; Ida, H; Iwanaga, N; Izumi, Y; Kamachi, M; Kawakami, A; Migita, K; Mingguo, H; Miyashita, T; Nakashima, K; Nishikaku, F; Origuchi, T; Tagashira, S; Tamai, M; Tanaka, F1

Other Studies

1 other study(ies) available for teprotide and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one

ArticleYear
Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells.
    Biochemical and biophysical research communications, 2003, Dec-12, Volume: 312, Issue:2

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Arthritis, Rheumatoid; Cells, Cultured; Chromones; Enzyme Activation; Humans; Membrane Glycoproteins; Mitochondria; Mitogen-Activated Protein Kinases; Morpholines; Platelet-Derived Growth Factor; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Synovial Membrane; Teprotide; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2003